Sodium-glucose co-transporter 2 (SGLT2) inhibitors, initially developed to treat type 2 diabetes, have significant heart- and ...
Sportschosun on MSN
SGLT2 inhibitors that lower blood sugar, protect heart and kidney...a key treatment for increasing s...
The final thesis of Professor Lim Soo's team of the Department of Endocrine Metabolism at Bundang Seoul National University ...
The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has directed Boehringer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback